02.05.2016
- AstraZeneca has agreed to grant exclusive rights for its Zurampic gout treatment in the US to partner Ironwood Pharmaceuticals. Zurampic was approved by the US Food and Drug...
28.04.2016
- As part of a newly announced collaboration with non-profit scientific institutes and high-tech companies, British-Swedish drugmaker AstraZeneca and its global biologics research...
19.04.2016
- As the drug world’s M&A carousel continues to turn, British-Swedish drugmaker Astra Zeneca is being eyed as the latest contender to enter the race to buy US biotech firm Medivation...
11.04.2016
- Eli Lilly and AstraZeneca are moving into Phase 3 of their Amaranth study of AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor that could be a potential treatment...
07.04.2016
- The targeted $160 billion merger between Pfizer and Allergan has run afoul of new anti-inversion legislation proposed by the US Treasury, as had been predicted by most deal...
04.04.2016
- Alliances between big pharma and scientists, hospitals and biotech firms are common practice in the health-care business. About half of today’s top-selling drugs are the result of...
04.04.2016
- Indian generic drug maker Sun Pharma has agreed to buy a portfolio of brands from Novartis for $293 million. The Mumbai-based multi-national is acquiring 14 established...
16.03.2016
- AstraZeneca shareholders are said to be questioning the £8.4 million pay package awarded to CEO executive Pascal Soriot last year after he successfully deflected a hostile bid from...
